πŸ‡ΊπŸ‡Έ FDA
Patent

US 11261230

Synthetic somatostatin receptor ligands

granted A61KA61K38/08A61K38/12

Quick answer

US patent 11261230 (Synthetic somatostatin receptor ligands) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/08, A61K38/12, A61K47/62, A61K47/6923